特宝生物
(688278)
| 流通市值：246.15亿 | | | 总市值：246.15亿 |
| 流通股本：4.07亿 | | | 总股本：4.07亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 655,378,671.04 | 412,956,945.26 | 525,694,947.27 | 317,421,572.18 |
| 应收票据及应收账款 | 397,987,170.72 | 441,022,155.69 | 290,335,382.85 | 351,544,124.49 |
| 其中：应收票据 | 3,230,355 | 3,211,662 | 909,849.8 | 1,788,766.74 |
| 应收账款 | 394,756,815.72 | 437,810,493.69 | 289,425,533.05 | 349,755,357.75 |
| 预付款项 | 34,378,893.94 | 23,389,114.21 | 26,566,379.46 | 31,673,316.66 |
| 其他应收款合计 | 31,779,925.95 | 17,800,218.99 | 36,172,757.91 | 15,894,220.26 |
| 其中:应收利息 | - | - | 87,739.73 | - |
| 存货 | 216,096,029.95 | 187,017,724.74 | 171,296,525.22 | 153,223,921.39 |
| 其他流动资产 | 976,514.44 | 923,793.45 | 379,983.68 | 178,600.28 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,336,597,206.04 | 1,340,191,036.92 | 1,160,609,813.02 | 900,042,796.36 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 52,863,797.4 | 37,350,684.93 | 35,000,000 | 35,000,000 |
| 固定资产 | 302,552,453.62 | 298,750,566.63 | 271,857,435.73 | 273,820,810.2 |
| 在建工程 | 244,991,859.76 | 183,715,136.39 | 127,921,164.59 | 128,226,696.83 |
| 使用权资产 | 8,145,334.45 | 8,387,072.11 | 9,835,980 | 10,754,265.82 |
| 无形资产 | 182,635,422.8 | 191,539,966.96 | 197,809,428.88 | 109,873,715.47 |
| 开发支出 | 173,157,902.03 | 161,110,873.96 | 220,376,785.24 | 310,303,949.22 |
| 长期待摊费用 | 16,393,114.21 | 15,590,758.66 | 19,417,690.01 | 9,028,777.56 |
| 递延所得税资产 | 40,530,714.57 | 43,662,001.45 | 42,861,275.49 | 44,528,795.11 |
| 其他非流动资产 | 69,045,472.81 | 75,788,996.16 | 51,605,706.52 | 42,247,298.68 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,090,316,071.65 | 1,015,896,057.25 | 976,685,466.46 | 963,784,308.89 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,426,913,277.69 | 2,356,087,094.17 | 2,137,295,279.48 | 1,863,827,105.25 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 43,811,900.36 | 40,624,624.97 | 34,300,642.51 | 59,626,939.13 |
| 应付账款 | 43,811,900.36 | 40,624,624.97 | 34,300,642.51 | 59,626,939.13 |
| 合同负债 | 67,565,171.32 | 60,053,059.95 | 59,589,065.34 | 33,361,835.97 |
| 应付职工薪酬 | 131,788,428.5 | 197,168,787.69 | 172,226,224.92 | 88,500,338.2 |
| 应交税费 | 52,413,128.59 | 65,090,483.07 | 58,091,885.29 | 36,987,001.35 |
| 其他应付款合计 | 47,367,575.23 | 36,414,615.48 | 15,330,492.72 | 21,060,073.17 |
| 一年内到期的非流动负债 | 4,524,695.7 | 4,163,351.22 | 5,135,689.81 | 5,435,414.38 |
| 其他流动负债 | 154,236.75 | 142,691.83 | 73,442.62 | 161,188.94 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 347,625,136.45 | 403,657,614.21 | 344,747,443.21 | 245,132,791.14 |
| 非流动负债: | | | | |
| 租赁负债 | 3,000,516.58 | 3,760,668.04 | 4,360,388.81 | 5,432,333.56 |
| 预计负债 | 31,418,928.71 | 31,246,034.77 | 36,675,517.36 | 28,661,444.36 |
| 递延收益 | 39,082,851.7 | 40,616,377.04 | 45,422,914.25 | 46,169,134.71 |
| 递延所得税负债 | 576,910.2 | 405,057.39 | 16,230,726.54 | 15,300,660.41 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 74,079,207.19 | 76,028,137.24 | 102,689,546.96 | 95,563,573.04 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 421,704,343.64 | 479,685,751.45 | 447,436,990.17 | 340,696,364.18 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 406,800,000 | 406,800,000 | 406,800,000 | 406,800,000 |
| 资本公积 | 397,038,962 | 397,038,962 | 397,038,962 | 397,038,962 |
| 盈余公积 | 117,548,442.81 | 117,548,442.81 | 72,963,779.06 | 72,963,779.06 |
| 未分配利润 | 1,083,821,529.24 | 955,013,937.91 | 813,055,548.25 | 646,328,000.01 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,005,208,934.05 | 1,876,401,342.72 | 1,689,858,289.31 | 1,523,130,741.07 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,005,208,934.05 | 1,876,401,342.72 | 1,689,858,289.31 | 1,523,130,741.07 |
| 负债和股东权益合计 | 2,426,913,277.69 | 2,356,087,094.17 | 2,137,295,279.48 | 1,863,827,105.25 |
| 公告日期 | 2024-04-23 | 2024-03-29 | 2023-10-20 | 2023-08-18 |
| 审计意见(境内) | | 标准无保留意见 | | |